EKF Diagnostics Holdings ( (GB:EKF) ) has shared an update.
EKF Diagnostics Holdings plc announced a share buyback of 278,000 ordinary shares at a weighted average price of 22.5 pence per share, which will be held in treasury. This move is part of a strategic effort to manage the company’s share capital and maintain the aggregate indirect beneficial interest of Mr. Mills, a non-executive director, at approximately the same level, ensuring it does not exceed 30% of the total voting rights. This buyback reflects EKF’s ongoing commitment to optimizing shareholder value and maintaining a balanced capital structure.
More about EKF Diagnostics Holdings
EKF Diagnostics Holdings plc is an AIM-listed global diagnostics business focused on providing point-of-care analyzers in hematology and diabetes, as well as life sciences services that include the specialist manufacture of enzymes and custom products for diagnostic, food, and industrial applications. The company is headquartered in Penarth, near Cardiff, and operates five manufacturing sites across the US and Germany, selling its products in over 120 countries worldwide.
YTD Price Performance: -20.37%
Average Trading Volume: 546,251
Technical Sentiment Signal: Strong Buy
Current Market Cap: £97.37M
For detailed information about EKF stock, go to TipRanks’ Stock Analysis page.